These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The role of mesalazine in Crohn's disease. Hanauer SB. Scand J Gastroenterol Suppl; 1990; 172():56-9. PubMed ID: 1972296 [Abstract] [Full Text] [Related]
5. Sulfasalazine and mesalazine for the maintenance therapy of Crohn's disease: a meta-analysis. Steinhart AH, Hemphill D, Greenberg GR. Am J Gastroenterol; 1994 Dec; 89(12):2116-24. PubMed ID: 7977225 [Abstract] [Full Text] [Related]
9. [Prevention of recurrence of chronic inflammatory bowel diseases]. Dölle W, Hartmann F. Verh Dtsch Ges Inn Med; 1989 Dec; 95():322-6. PubMed ID: 2574922 [No Abstract] [Full Text] [Related]
10. Is Asacol as effective as sulphasalazine in maintaining remission of Crohn's disease and ulcerative colitis? Nakshabendi IM, Duncan A, Russell RI. Postgrad Med J; 1992 Mar; 68(797):189-91. PubMed ID: 1350343 [Abstract] [Full Text] [Related]
11. [Current medical therapies for Crohn's disease in Japan]. Munakata A, Haga Y. Nihon Geka Gakkai Zasshi; 1997 Apr; 98(4):406-11. PubMed ID: 9168493 [Abstract] [Full Text] [Related]
12. Sulfasalazine and new analogues. Friedman G. Am J Gastroenterol; 1986 Feb; 81(2):141-4. PubMed ID: 2868653 [No Abstract] [Full Text] [Related]
20. Will there be a next generation of sulfasalazine? Goldman P. Gastroenterology; 1982 Nov; 83(5):1138-41. PubMed ID: 6126420 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]